Distinguished Professor Nan-Shan Chang at the Institute of Molecular Medicine at NCKU, who discovered a small drug peptide named Zfra or dubbed “Zffi”, signed a cooperation agreement with an Indian Biopharmaceutical company Lazuline Biotech Pvt. Ltd (www.lazulinebio.com) based at Hyderabad early in September this year. Both research teams will work together on Zffi for drug and vaccine development. Hopefully, clinical trials for Zffi in treating cancer and Alzheimer’s disease (AD) will start in India sometime between 2022 and 2023. This marks a significant milestone in recent international collaborations.